Method for alleviating keratoconjunctivitis sicca

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/165 (2006.01) A61K 31/167 (2006.01) A61K 31/56 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2644733

An improved method of increasing tear production is by intranasally administering a therapeutically effective amount of a capsaicinoid compound to patients with deficient tear production. Optional incorporation into the intranasal formulation of a topical corticosteroid or topical anesthetic compound is used to reduce transient nasal stinging and burning which may sometimes accompany intranasal administration of capsaicinoids.

L'invention porte sur un procédé amélioré pour augmenter la production de larmes par administration intranasale d'une quantité thérapeutiquement efficace d'un composé capsaicinoïde à des patients ayant une production de larmes déficiente. Une incorporation facultative dans la formulation intranasale d'un corticostéroïde topique ou d'un composé anesthésique topique est utilisée pour réduire la sensation urticante et brûlante nasale transitoire qui peut parfois accompagner l'administration intranasale des capsaicinoïdes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for alleviating keratoconjunctivitis sicca does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for alleviating keratoconjunctivitis sicca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for alleviating keratoconjunctivitis sicca will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1411932

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.